Michael Edward Nickas

Michael Nickas practices at Brown & Toland Medical Group in Castro Valley, California.

Michael Nickas' NPI, 1770572760, was assigned on October 21, 2005. Michael Nickas graduated from Feinberg School of Medicine in 1989. Michael Nickas holds California license G70673.

Michael Nickas' primary practice is Brown & Toland Medical Group, at 20055 Lake Chabot Rd, Castro Valley, CA 94546 in Alameda County. The practice phone is (415) 972-6000.

Michael Nickas' primary practice is Brown & Toland Medical Group in Castro Valley, California. Michael Nickas is also affiliated with Sutter Eden Medical Center. Dmand AI also links Michael Nickas to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Nickas practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Michael Nickas' primary specialty in the NPI Registry, under taxonomy code 208800000X. Michael Nickas is board certified in urology by the American Board of Urology. Michael Nickas is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Michael Nickas treats.

CMS data shows 968 Medicare services from Michael Nickas across 11 procedure codes in 2024, for 428 Medicare patients. Medicare paid $97,165 for them.

CMS counts 428 Medicare patients who saw Michael Nickas in 2024. The largest group is 75 to 84, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Nickas' median patient age at 75, with 11% women.

In 2024, Michael Nickas wrote 1,032 Medicare Part D claims for 285 patients. 96% of them were for generic drugs. CMS names the drug for 917 of them, across 11 drugs with 11 or more claims each, at $47,973 in total drug cost. In 2023, CMS named 848 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 30 out of 100 for Michael Nickas for performance year 2024, reported individually. Michael Nickas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of prostate resection by Michael Nickas, more than 60% of the clinicians it reports for that procedure.

CMS Open Payments shows 2 general payments to Michael Nickas from 2 drug and device companies from 2019 to 2021. Consulting fees make up the largest share, 87% of the total. Merck Sharp & Dohme Corporation paid the most, $100.

Dmand AI lists 1 award for Michael Nickas, most recently Regional Top Doctor in 2014.

Michael Nickas graduated from Feinberg School of Medicine in 1989.

Michael Nickas is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.